FDA issues two draft guidance documents focused on donor eligibility and current good manufacturing practices for manufacturers of animal cells, tissues, and cell- and tissue-based products that, if finalized, may help support the development of promising and innovative products that can benefit ani
Read more: FDA Issues Draft Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals